2010
DOI: 10.1186/1471-2407-10-289
View full text
|
|
Share

Abstract: BackgroundDiabetes is associated with an increased risk of several malignancies. Both diabetic patients and patients with cancer have an increase in platelet reactivity and platelet activation has recently emerged as a potential mediator of cancer progression. Drug therapies, such as aspirin, that reduce platelet reactivity reduce both cardiovascular and cancer risk.MethodsWe performed a cross-sectional analysis to assess the association between history of cancer and current anti-platelet drug use in a primary…

Expand abstract

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
2
0

Publication Types

Select...

Relationship

0
0

Authors

Journals